Quantbot Technologies LP Takes Position in Mettler-Toledo International Inc. (NYSE:MTD)

Quantbot Technologies LP bought a new stake in Mettler-Toledo International Inc. (NYSE:MTDFree Report) in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund bought 2,106 shares of the medical instruments supplier’s stock, valued at approximately $2,577,000.

Several other institutional investors and hedge funds have also made changes to their positions in MTD. SBI Securities Co. Ltd. purchased a new stake in Mettler-Toledo International during the 4th quarter valued at approximately $33,000. Blue Trust Inc. raised its stake in Mettler-Toledo International by 70.8% during the 4th quarter. Blue Trust Inc. now owns 41 shares of the medical instruments supplier’s stock valued at $50,000 after acquiring an additional 17 shares during the last quarter. Whipplewood Advisors LLC purchased a new stake in Mettler-Toledo International during the 4th quarter valued at approximately $54,000. Sound Income Strategies LLC raised its stake in Mettler-Toledo International by 4,500.0% during the 4th quarter. Sound Income Strategies LLC now owns 46 shares of the medical instruments supplier’s stock valued at $56,000 after acquiring an additional 45 shares during the last quarter. Finally, Farther Finance Advisors LLC raised its stake in Mettler-Toledo International by 14.3% during the 4th quarter. Farther Finance Advisors LLC now owns 64 shares of the medical instruments supplier’s stock valued at $78,000 after acquiring an additional 8 shares during the last quarter. 95.07% of the stock is owned by hedge funds and other institutional investors.

Mettler-Toledo International Price Performance

MTD opened at $1,198.09 on Friday. The stock has a market cap of $24.97 billion, a P/E ratio of 29.56, a P/E/G ratio of 3.30 and a beta of 1.15. The stock’s 50 day simple moving average is $1,292.72 and its 200 day simple moving average is $1,310.23. Mettler-Toledo International Inc. has a 1-year low of $1,142.91 and a 1-year high of $1,546.93.

Mettler-Toledo International (NYSE:MTDGet Free Report) last released its quarterly earnings results on Thursday, February 13th. The medical instruments supplier reported $12.41 earnings per share for the quarter, topping analysts’ consensus estimates of $11.76 by $0.65. Mettler-Toledo International had a negative return on equity of 591.54% and a net margin of 22.29%. Research analysts expect that Mettler-Toledo International Inc. will post 42.71 EPS for the current fiscal year.

Insider Buying and Selling at Mettler-Toledo International

In related news, insider Gerry Keller sold 600 shares of the stock in a transaction on Monday, February 10th. The stock was sold at an average price of $1,351.34, for a total value of $810,804.00. Following the transaction, the insider now directly owns 6 shares of the company’s stock, valued at approximately $8,108.04. This trade represents a 99.01 % decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, insider Christian Magloth sold 790 shares of the stock in a transaction on Monday, February 24th. The stock was sold at an average price of $1,313.69, for a total value of $1,037,815.10. Following the completion of the transaction, the insider now directly owns 734 shares in the company, valued at $964,248.46. This trade represents a 51.84 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.94% of the stock is owned by insiders.

Analysts Set New Price Targets

Several analysts have commented on the company. Citigroup reduced their price objective on Mettler-Toledo International from $1,450.00 to $1,400.00 and set a “neutral” rating for the company in a research note on Tuesday, March 4th. Wells Fargo & Company upped their price objective on Mettler-Toledo International from $1,350.00 to $1,400.00 and gave the company an “equal weight” rating in a research note on Monday, February 10th. Wolfe Research assumed coverage on Mettler-Toledo International in a research note on Friday, December 13th. They set a “peer perform” rating for the company. Evercore ISI increased their target price on Mettler-Toledo International from $1,450.00 to $1,475.00 and gave the stock an “outperform” rating in a research note on Monday, February 10th. Finally, Robert W. Baird increased their target price on Mettler-Toledo International from $1,362.00 to $1,369.00 and gave the stock a “neutral” rating in a research note on Monday, February 10th. One equities research analyst has rated the stock with a sell rating, six have given a hold rating and three have given a buy rating to the stock. According to MarketBeat.com, Mettler-Toledo International presently has a consensus rating of “Hold” and an average target price of $1,380.50.

View Our Latest Report on MTD

Mettler-Toledo International Company Profile

(Free Report)

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company’s laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.

Read More

Institutional Ownership by Quarter for Mettler-Toledo International (NYSE:MTD)

Receive News & Ratings for Mettler-Toledo International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mettler-Toledo International and related companies with MarketBeat.com's FREE daily email newsletter.